SPARC — Sun Pharma Advanced Research Co Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹83.52bn
- IN₹79.87bn
- IN₹2.39bn
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,109 | 88.4 | 157 | 157 | 4,066 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 386 | 529 | 385 | 519 | 439 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,574 | 672 | 598 | 712 | 4,550 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 811 | 1,066 | 951 | 951 | 1,073 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 3,985 | 2,726 | 2,297 | 2,801 | 8,301 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 950 | 2,354 | 2,334 | 1,714 | 1,789 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,022 | 2,912 | 3,979 | 2,489 | 3,174 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2,962 | -186 | -1,683 | 312 | 5,128 |
Total Liabilities & Shareholders' Equity | 3,985 | 2,726 | 2,297 | 2,801 | 8,301 |
Total Common Shares Outstanding |